Arca
Skip to content
Tools
Tools

Voltage-gated L-type calcium channel

Family in Homo sapiens that 24 drugs act on.

  • Drugs that act on it: 24
  • Approved: 13
  • In phases 1 to 3: 11
  • Sponsors: 15
  • Genes: 4

Who is on it, and how far along

Every drug ChEMBL records acting on CACNA1C, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 24

Approved13

  • Amlodipine
  • Verapamil
  • Nifedipine
  • Nimodipine
  • Nicardipine
  • Diltiazem
  • Dronedarone
  • Clevidipine
  • Levamlodipine
  • Cinnarizine
  • Felodipine
  • Isradipine
  • Nisoldipine

Phase 38

  • Lercanidipine
  • Benidipine
  • Cilnidipine
  • Lacidipine
  • Nilvadipine
  • Nitrendipine
  • Azelnidipine
  • Manidipine 6300

Phase 23

  • Barnidipine
  • AZD1305
  • Elpetrigine

Phase 10

    Sponsors

    Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

    The landscape

    Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Voltage-gated L-type calcium channel blocker.
    AmlodipineApprovedHK inno.N CorporationSmall moleculeBlocker61
    VerapamilApprovedMT AdamsSmall moleculeBlocker28
    NifedipineApprovedPfizerSmall moleculeBlocker22
    NimodipineBoxed warningApprovedBayerSmall moleculeBlocker16
    NicardipineApprovedChiesi GroupSmall moleculeBlocker14
    DiltiazemApprovedGSKSmall moleculeBlocker12
    DronedaroneBoxed warningApprovedSanofiSmall moleculeBlocker8
    ClevidipineApprovedChiesi GroupSmall moleculeBlocker3
    LevamlodipineApprovedCSPC Pharmaceutical GroupSmall moleculeBlocker3
    CinnarizineApprovedValenta Pharm JSCSmall moleculeBlocker1
    FelodipineApprovedAstraZeneca PharmaceuticalsSmall moleculeBlocker1
    IsradipineApprovedGSKSmall moleculeBlocker1
    NisoldipineApprovedAzurity PharmaceuticalsSmall moleculeBlocker0
    LercanidipinePhase 3LG Life SciencesSmall moleculeBlocker3
    BenidipinePhase 3—Small moleculeBlocker1
    CilnidipinePhase 3IlDong Pharmaceutical Co LtdSmall moleculeBlocker1
    LacidipinePhase 3Boehringer Ingelheim PharmaceuticalsSmall moleculeBlocker1
    NilvadipinePhase 3—Small moleculeBlocker1
    NitrendipinePhase 3Daiichi SankyoSmall moleculeBlocker1
    AzelnidipinePhase 3—Small moleculeBlocker0
    Manidipine 6300Phase 3—Small moleculeBlocker0
    BarnidipinePhase 2—Small moleculeBlocker1
    AZD1305Phase 2AstraZeneca PharmaceuticalsSmall moleculeBlocker0
    ElpetriginePhase 2—Small moleculeBlocker0

    Open trials

    The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 60 in all, from ClinicalTrials.gov.
    Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential HypertensionAmlodipine—RecruitingHK inno.N CorporationNov 12, 2026
    Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential HypertensionAmlodipinePhase 4Not yet recruitingChina National Center for Cardiovascular DiseasesNov 12, 2026
    A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination TherapyLevamlodipine, Amlodipine—Not yet recruitingAhn-Gook Pharmaceuticals Co.,LtdOct 30, 2026
    A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial FibrillationDiltiazemPhase 4Not yet recruitingUniversity Hospital, Basel, SwitzerlandOct 29, 2026
    Comparing Inclisiran Versus Statin for Primary AldosteronismAmlodipineNot applicableRecruitingThird Military Medical UniversityOct 21, 2026
    Verapamil In Preclinical Type 1 DiabetesVerapamilPhase 2 / Phase 3Not yet recruitingAssistance Publique - Hôpitaux de ParisOct 19, 2026
    Ramipril vs. Amlodipine in Pediatric Hemodialysis PatientsAmlodipinePhase 3Not yet recruitingAin Shams UniversityOct 19, 2026
    Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose Combination of Perindopril and Amlodipine in Patients With Uncontrolled Essential HypertensionAmlodipine—Active, not recruitingBosnalijek D.DOct 15, 2026
    Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney DamageAmlodipinePhase 4RecruitingShanghai Jiao Tong University School of MedicineOct 15, 2026
    Fasciotomy and Predilation for Radial Artery Grafts in CABGVerapamilNot applicableRecruitingRuijin HospitalOct 9, 2026
    VITAL: Real-World Evaluation of Amlodipine/Valsartan.Amlodipine—Active, not recruitingVIVA PHARM LLPSep 29, 2026
    Oral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 DiabetesVerapamilPhase 2 / Phase 3RecruitingAin Shams UniversitySep 4, 2026
    Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult SubjectsVerapamilPhase 1Not yet recruitingJiangsu vcare pharmaceutical technology co., LTDSep 1, 2026
    Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST TrialNifedipinePhase 3Not yet recruitingThe George Washington University Biostatistics CenterAug 5, 2026
    Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)VerapamilPhase 4Not yet recruitingMuhammad Ali JavedJul 15, 2026
    Verapamil Effect in Cystic Fibrosis-related DysglycemiaVerapamilPhase 2Not yet recruitingRhode Island HospitalJul 7, 2026
    Effects of Nimodipine on Alcohol DrinkingNimodipinePhase 2Not yet recruitingYale UniversityJul 2, 2026
    Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal SurgeryNicardipineNot applicableNot yet recruitingSaglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalJun 22, 2026
    Remifentanil Monotherapy vs. Remifentanil-Nicardipine for Controlled Hypotension in Otolaryngological SurgeryNicardipineNot applicableNot yet recruitingDicle UniversityJun 22, 2026
    Oral Nifedipine Versus Placebo for Pain and Healing After HemorrhoidectomyNifedipinePhase 4Not yet recruitingSana'a UniversityJun 22, 2026
    Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)VerapamilPhase 4Not yet recruitingStanford UniversityJun 17, 2026
    Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageNimodipineNot applicableNot yet recruitingBeijing Tiantan HospitalJun 12, 2026
    Key Diagnostic & Therapeutic Technologies for Severe Acute High Altitude Disease (SAHAD): Integration and ApplicationNifedipineNot applicableNot yet recruitingTibet Autonomous Region People's HospitalJun 10, 2026
    A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure.LevamlodipinePhase 3Not yet recruitingZentiva, k.s.Jun 1, 2026
    Efficacy of Early Rhythm Control in AF With TR PatientsDronedarone—RecruitingSamsung Medical CenterMay 26, 2026
    EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory FailureNicardipineNot applicableNot yet recruitingFirst Affiliated Hospital of Wannan Medical CollegeMay 22, 2026
    Transradial vs Transfemoral Group-Randomized Efficacy and Safety Trial for Cerebral AngiographyVerapamilNot applicableNot yet recruitingGansu Provincial Maternal and Child Health Care HospitalApr 22, 2026
    Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine TherapyDiltiazemPhase 1 / Phase 2RecruitingMayo ClinicMar 9, 2026
    Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial FibrillationDronedaroneNot applicableRecruitingSamsung Medical CenterMar 3, 2026
    Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular ComplexesDiltiazemNot applicableRecruitingWestern Sydney Local Health DistrictMar 3, 2026
    Flecainide Safety in Patients With Coronary Artery Disease and Atrial FibrillationDiltiazemPhase 4RecruitingUniversitaire Ziekenhuizen KU LeuvenFeb 12, 2026
    Pharmacometric Modeling of a Hospital PreparationNicardipine—Not yet recruitingUniversity Hospital, RouenJan 28, 2026
    Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension StudyNifedipineNot applicableRecruitingThe Cleveland ClinicJan 23, 2026
    Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced HypertensionNimodipine—RecruitingRegion StockholmDec 26, 2025
    Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular CarcinomaNicardipinePhase 2 / Phase 3RecruitingUniversity Hospital, Basel, SwitzerlandDec 24, 2025
    Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal DiseaseNifedipine—RecruitingCardarelli HospitalDec 22, 2025
    Dronedarone Rhythm Intervention for Early Atrial FibrillationDronedaronePhase 4Not yet recruitingInha University HospitalDec 8, 2025
    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort StudyClevidipine, Felodipine, Isradipine, Nicardipine, Nifedipine, Nimodipine, Barnidipine, Benidipine, Cilnidipine, Diltiazem, Lacidipine, Lercanidipine, Nilvadipine, Nitrendipine—Not yet recruitingFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineDec 4, 2025
    Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid HemorrhageNicardipinePhase 4Not yet recruitingWake Forest University Health SciencesNov 24, 2025
    Anesthesia Management in Endovascular Therapy for Ischemic Stroke - 2NicardipineNot applicableRecruitingUniversity Hospital, Clermont-FerrandNov 19, 2025
    Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot StudyNifedipineNot applicableRecruitingMedical College of WisconsinSep 22, 2025
    6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 WeeksNifedipine—RecruitingAssistance Publique - Hôpitaux de ParisAug 28, 2025
    Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid HemorrhageNimodipinePhase 3Not yet recruitingCentre Hospitalier St AnneAug 28, 2025
    The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular ObstructionDiltiazemPhase 4Enrolling by invitationSecond Affiliated Hospital, Zhejiang University, School of MedicineAug 5, 2025
    PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency DepartmentDiltiazem—RecruitingUniversity of IowaJul 25, 2025
    Nimodipine Variability in SAHNimodipine—RecruitingUniversity of AlbertaJul 15, 2025
    Perioperative Intravenous Nimodipine TrialNimodipineNot applicableRecruitingUniversity of IoanninaJul 2, 2025
    NICardipine for Fast Achievement of Systolic BP Targets in ICHNimodipinePhase 4RecruitingAarhus University HospitalJun 29, 2025
    The Role of Skin Sodium Accumulation in Chronic Kidney DiseaseLercanidipineNot applicableRecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Jun 13, 2025
    Adenosine vs Diltiazem for Treatment of SVT in the EDDiltiazemPhase 4RecruitingAnne E. ZepeskiMay 28, 2025
    A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsLevamlodipinePhase 3Not yet recruitingCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Jan 13, 2025
    Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial FibrillationDronedaroneNot applicableRecruitingSeoul National University HospitalNov 21, 2024
    Clevidipine for the Antihypertensive Treatment of Acute Intracerebral HemorrhageClevidipine—RecruitingZeenat Qureshi Stroke InstituteMay 7, 2024
    Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional VertigoCinnarizinePhase 4RecruitingValenta Pharm JSCMar 20, 2024
    Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)DronedaroneNot applicableRecruitingThe First Affiliated Hospital with Nanjing Medical UniversityNov 9, 2023
    Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationDronedaroneNot applicableActive, not recruitingBoston Scientific CorporationOct 23, 2023
    Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General AnesthesiaClevidipinePhase 4Not yet recruitingUniversity of California, San DiegoOct 3, 2023
    First-line Cryoablation for Early Treatment of Persistent Atrial FibrillationDronedaronePhase 3Not yet recruitingRegion Örebro CountyJul 11, 2023
    Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKEDronedaronePhase 3RecruitingUniversitätsklinikum Hamburg-EppendorfMar 24, 2022
    Bariatric Surgery and Pharmacokinetics of LercanidipineLercanidipine—RecruitingNorwegian University of Science and TechnologyApr 13, 2018

    Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2095229, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

    Esc

    Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

    Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.